Aurigene Pharmaceutical Services Ltd has announced its plans to establish a cutting-edge biomanufacturing facility in Hyderabad, investing USD 40 million (approximately INR 330 Crores). The facility is expected to create employment opportunities for over 250 individuals.
KT Rama Rao, the Minister for IT and Industries in Telangana highlighted in a tweet that Hyderabad offers a conducive ecosystem for biologics Research and Development, accounting for 30-40 percent of India’s total biologics capacity. The company has ambitious expansion goals for the facility and aims to explore novel therapies, particularly in the field of cell and gene therapies.
As a leading contract research, development, and manufacturing organization (CRO/CDMO), Aurigene Pharmaceutical Services, based in Hyderabad, serves as a long-term partner, offering comprehensive solutions to accelerate innovation in the pharmaceutical industry.
Biltrax Construction Data is tracking 25,000+ projects on their technology platform for their clients.
Get exclusive access to upcoming projects in India with actionable insights and gain a competitive advantage for your products in the Indian Construction Market.
Visit www.biltrax.com or email us at contact@biltrax.com to become a subscriber and generate leads.
Disclaimer: The information contained herein has been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. All such information and opinions can be subject to change. The image featured in this article is for representation purposes only and does not in any way represent the project. If you wish the article to be removed or edited, please email editor@biltrax.com.
0Discover more from Biltrax Media, A Biltrax Group venture
Subscribe to get the latest posts sent to your email.
